HR Execs on the Move

Spark Therapeutics

www.sparktx.com

 
At Spark Therapeutics, we don`t follow footsteps. We create the path. We were born of innovation, springing from the curiosity, imagination and dedication of remarkable scientists and healthcare visionaries. Our mission is seemingly impossible to others, but not to us: Challenge the inevitability of genetic disease by discovering, developing and delivering treatments in ways unimaginable – until now. Since our founding, we have been committed to bringing a wide range of expertise to build a fully integrated gene therapy company focused on inherited retinal diseases (IRDs), neurodegenerative diseases, as well as diseases that can be addressed by targeting the liver, ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.sparktx.com
  • 3737 Market Street
    Philadelphia, PA USA 19104
  • Phone: 215.220.9300

Executives

Name Title Contact Details
Mia Belk
Associate General Counsel - HR and Strategy Profile
Luann Sievern
VP, Head of Procurement Profile
Amy Shillingford
Head of HR Operations and Technology Profile
Will Smiley
Head of Talent Acquisition Profile
Lisa Dalton
Chief Human Resources Officer Profile

Similar Companies

BioSearch

BioSearch is a Falls Church, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GenVault Corporation

GenVault Corporation is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Clementia Pharmaceuticals

Clementia is a biopharmaceutical company that is focused on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease. Our lead program is palovarotene for Fibrodysplasia Ossificans Progressiva (FOP).

BIOMERIX

BIOMERIX is a Fremont, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioAge Labs

BIOAGE has a diverse team of computational biologists and medical scientists with expertise in aging and translational research. We share the vision that a synergy of machine learning approaches, high throughput human omics data, and new experimental approaches will make it possible to discover therapies that address unmet medical needs in an aging population.